Fastly Valuation
Is FSLY * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of FSLY * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: FSLY * (MX$214) is trading below our estimate of fair value (MX$233.86)
Significantly Below Fair Value: FSLY * is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for FSLY *?
Other financial metrics that can be useful for relative valuation.
What is FSLY *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$1.77b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 3.7x |
Enterprise Value/EBITDA | -14.2x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does FSLY *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 4.4x | ||
GDS GDS Holdings | 1.1x | 13.6% | US$1.5b |
9449 GMO internet group | 1.1x | 8.5% | JP¥273.0b |
BASE Couchbase | 7.1x | 14.0% | US$1.3b |
300738 Guangdong Aofei Data Technology | 8.3x | 20.7% | CN¥11.4b |
FSLY * Fastly | 3.5x | 12.6% | Mex$1.8b |
Price-To-Sales vs Peers: FSLY * is good value based on its Price-To-Sales Ratio (3.5x) compared to the peer average (4.3x).
Price to Earnings Ratio vs Industry
How does FSLY *'s PE Ratio compare vs other companies in the Global IT Industry?
Price-To-Sales vs Industry: FSLY * is expensive based on its Price-To-Sales Ratio (3.5x) compared to the Global IT industry average (1.4x).
Price to Sales Ratio vs Fair Ratio
What is FSLY *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 3.5x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate FSLY *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$214.00 | Mex$340.78 +59.2% | 16.2% | Mex$464.70 | Mex$258.17 | n/a | 11 |
Apr ’25 | Mex$213.00 | Mex$341.25 +60.2% | 12.4% | Mex$448.85 | Mex$299.24 | n/a | 11 |
Mar ’25 | Mex$249.00 | Mex$368.20 +47.9% | 15.2% | Mex$477.30 | Mex$306.84 | n/a | 10 |
Feb ’25 | Mex$353.89 | Mex$362.43 +2.4% | 14.0% | Mex$480.95 | Mex$309.18 | n/a | 10 |
Jan ’25 | Mex$309.99 | Mex$339.74 +9.6% | 24.4% | Mex$467.69 | Mex$194.14 | n/a | 10 |
Dec ’24 | Mex$300.00 | Mex$339.74 +13.2% | 24.4% | Mex$467.69 | Mex$194.14 | n/a | 10 |
Nov ’24 | Mex$256.00 | Mex$341.11 +33.2% | 25.5% | Mex$472.03 | Mex$178.12 | n/a | 10 |
Oct ’24 | Mex$334.92 | Mex$327.96 -2.1% | 25.5% | Mex$453.84 | Mex$171.26 | n/a | 10 |
Sep ’24 | Mex$412.00 | Mex$319.20 -22.5% | 24.5% | Mex$444.14 | Mex$167.60 | n/a | 11 |
Aug ’24 | Mex$308.00 | Mex$311.52 +1.1% | 28.2% | Mex$455.17 | Mex$137.41 | n/a | 11 |
Jul ’24 | Mex$262.00 | Mex$311.52 +18.9% | 28.2% | Mex$455.17 | Mex$137.41 | n/a | 11 |
Jun ’24 | Mex$288.00 | Mex$298.21 +3.5% | 32.5% | Mex$471.15 | Mex$142.23 | n/a | 11 |
May ’24 | Mex$271.00 | Mex$294.63 +8.7% | 34.6% | Mex$477.14 | Mex$144.04 | n/a | 11 |
Apr ’24 | Mex$318.00 | Mex$272.84 -14.2% | 31.6% | Mex$458.90 | Mex$146.85 | Mex$213.00 | 11 |
Mar ’24 | Mex$245.00 | Mex$272.84 +11.4% | 31.6% | Mex$458.90 | Mex$146.85 | Mex$249.00 | 11 |
Feb ’24 | Mex$193.50 | Mex$213.84 +10.5% | 48.8% | Mex$472.34 | Mex$113.36 | Mex$353.89 | 11 |
Jan ’24 | Mex$137.50 | Mex$223.01 +62.2% | 47.9% | Mex$488.66 | Mex$117.28 | Mex$309.99 | 11 |
Dec ’23 | Mex$180.00 | Mex$223.01 +23.9% | 47.9% | Mex$488.66 | Mex$117.28 | Mex$300.00 | 11 |
Nov ’23 | Mex$168.00 | Mex$270.20 +60.8% | 38.1% | Mex$496.69 | Mex$119.20 | Mex$256.00 | 10 |
Oct ’23 | Mex$180.00 | Mex$281.75 +56.5% | 32.2% | Mex$496.03 | Mex$178.57 | Mex$334.92 | 10 |
Sep ’23 | Mex$175.00 | Mex$281.75 +61.0% | 32.2% | Mex$496.03 | Mex$178.57 | Mex$412.00 | 10 |
Aug ’23 | Mex$230.00 | Mex$343.07 +49.2% | 45.1% | Mex$719.02 | Mex$184.89 | Mex$308.00 | 10 |
Jul ’23 | Mex$222.00 | Mex$388.08 +74.8% | 32.2% | Mex$709.28 | Mex$263.45 | Mex$262.00 | 10 |
Jun ’23 | Mex$254.58 | Mex$388.08 +52.4% | 32.2% | Mex$709.28 | Mex$263.45 | Mex$288.00 | 10 |
May ’23 | Mex$323.00 | Mex$460.82 +42.7% | 23.7% | Mex$713.66 | Mex$305.85 | Mex$271.00 | 10 |
Apr ’23 | Mex$375.00 | Mex$468.60 +25.0% | 20.1% | Mex$694.95 | Mex$317.69 | Mex$318.00 | 10 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.